ArticlePharmacoEconomics - open2026
Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling.
Adam Martin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.